Covid-19 Infection in Children and Adolescents and Its Association with Type 1 Diabetes Mellitus (T1d) Presentation and Management

Overview

Journal Endocrine

Specialty Endocrinology

Date 2022 Dec 3

PMID 36462147

Authors

Kyriaki Karavanaki

Kalliopi Rodolaki

Alexandra Soldatou

Spyridon Karanasios

Kostas Kakleas

Affiliations

Soon will be listed here.

Abstract

Children seem to be affected by the new SARS-CoV-2 virus less severely than adults, with better prognosis and low mortality. Serious complications of COVID-19 infection in children include multisystem inflammatory response syndrome in COVID-19 infection (MIS-C), myo-or pericarditis and, less frequently, long COVID syndrome. On the other hand, adults with type 1 (T1D) or type 2 diabetes (T2D) are among the most vulnerable groups affected by COVID-19, with increased morbidity and mortality. Moreover, an association of SARS-CoV-2 with diabetes has been observed, possibly affecting the frequency and severity of the first clinical presentation of T1D or T2D, as well as the development of acute diabetes after COVID-19 infection. The present review summarizes the current data on the incidence of T1D among children and adolescents during the COVID-19 pandemic, as well as its severity. Moreover, it reports on the types of newly diagnosed diabetes after COVID infection and the possible pathogenetic mechanisms. Additionally, this study presents current data on the effect of SARS-CoV-2 on diabetes control in patients with known T1D and on the severity of clinical presentation of COVID infection in these patients. Finally, this review discusses the necessity of immunization against COVID 19 in children and adolescents with T1D.

Citing Articles

COVID-19 vaccines and blood glucose control: Friend or foe?.

Vena W, Pigni S, Betella N, Navarra A, Mirani M, Mazziotti G Hum Vaccin Immunother. 2024; 20(1):2363068.

PMID: 38860457 PMC: 11178329. DOI: 10.1080/21645515.2024.2363068.

Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.

Aparicio C, Willis Z, Nakamura M, Wolf J, Little C, Maron G J Pediatric Infect Dis Soc. 2024; 13(7):352-362.

PMID: 38780125 PMC: 11519042. DOI: 10.1093/jpids/piae052.

Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce.

Willis Z, Oliveira C, Abzug M, Anosike B, Ardura M, Bio L J Pediatric Infect Dis Soc. 2024; 13(3):159-185.

PMID: 38339996 PMC: 11494238. DOI: 10.1093/jpids/piad116.

Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.

Aparicio C, Willis Z, Nakamura M, Wolf J, Little C, Maron G medRxiv. 2024; .

PMID: 38293040 PMC: 10827273. DOI: 10.1101/2024.01.17.24301452.

Covid 19 and diabetes in children: advances and strategies.

Wu Z, Wang J, Ullah R, Chen M, Huang K, Dong G Diabetol Metab Syndr. 2024; 16(1):28.

PMID: 38287388 PMC: 10823738. DOI: 10.1186/s13098-024-01267-2.

References

Du Y, Chen L, Shi Y . Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta-Analysis. Front Public Health. 2022; 10:829176. PMC: 9046659. DOI: 10.3389/fpubh.2022.829176. View

Parums D . Editorial: Long-Term Effects of Symptomatic and Asymptomatic SARS-CoV-2 Infection in Children and the Changing Pathogenesis of Common Childhood Viruses Driven by the COVID-19 Pandemic. Med Sci Monit. 2022; 28:e937927. PMC: 9354561. DOI: 10.12659/MSM.937927. View

Craig M, Nair S, Stein H, Rawlinson W . Viruses and type 1 diabetes: a new look at an old story. Pediatr Diabetes. 2013; 14(3):149-58. DOI: 10.1111/pedi.12033. View

Sen S, Chakraborty R, Kalita P, Pathak M . Diabetes mellitus and COVID-19: Understanding the association in light of current evidence. World J Clin Cases. 2021; 9(28):8327-8339. PMC: 8554438. DOI: 10.12998/wjcc.v9.i28.8327. View

Siebach M, Piedimonte G, Ley S . COVID-19 in childhood: Transmission, clinical presentation, complications and risk factors. Pediatr Pulmonol. 2021; 56(6):1342-1356. PMC: 8137603. DOI: 10.1002/ppul.25344. View

Chen J, Lau Y, Lamirande E, Paddock C, Bartlett J, Zaki S . Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J Virol. 2009; 84(3):1289-301. PMC: 2812346. DOI: 10.1128/JVI.01281-09. View

Cheng H, Wong J, Selveindran N, Hong J . Impact of COVID-19 lockdown on glycaemic control and lifestyle changes in children and adolescents with type 1 and type 2 diabetes mellitus. Endocrine. 2021; 73(3):499-506. PMC: 8270233. DOI: 10.1007/s12020-021-02810-1. View

Hollstein T, Schulte D, Schulz J, Gluck A, Ziegler A, Bonifacio E . Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report. Nat Metab. 2020; 2(10):1021-1024. DOI: 10.1038/s42255-020-00281-8. View

Borchering R, Mullany L, Howerton E, Chinazzi M, Smith C, Qin M . Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: A multi-model study. Lancet Reg Health Am. 2022; 17:100398. PMC: 9679449. DOI: 10.1016/j.lana.2022.100398. View

10.

Diorio C, Henrickson S, Vella L, McNerney K, Chase J, Burudpakdee C . Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Invest. 2020; 130(11):5967-5975. PMC: 7598044. DOI: 10.1172/JCI140970. View

11.

Naguib M, Raymond J, Vidmar A . New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID-19. J Pediatr Endocrinol Metab. 2020; 34(1):147-150. DOI: 10.1515/jpem-2020-0426. View

12.

Yamamoto L, Dos Santos E, Pinto L, Rocha M, Kanunfre K, Vallada M . SARS-CoV-2 infections with emphasis on pediatric patients: a narrative review. Rev Inst Med Trop Sao Paulo. 2020; 62:e65. PMC: 7477958. DOI: 10.1590/S1678-9946202062065. View

13.

Rewers M, Hyoty H, Lernmark A, Hagopian W, She J, Schatz D . The Environmental Determinants of Diabetes in the Young (TEDDY) Study: 2018 Update. Curr Diab Rep. 2018; 18(12):136. PMC: 6415767. DOI: 10.1007/s11892-018-1113-2. View

14.

Yang J, Lin S, Ji X, Guo L . Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2009; 47(3):193-9. PMC: 7088164. DOI: 10.1007/s00592-009-0109-4. View

15.

Davies P, Evans C, Kanthimathinathan H, Lillie J, Brierley J, Waters G . Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health. 2020; 4(9):669-677. PMC: 7347350. DOI: 10.1016/S2352-4642(20)30215-7. View

16.

Cheng M, Zhang S, Porritt R, Noval Rivas M, Paschold L, Willscher E . Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc Natl Acad Sci U S A. 2020; 117(41):25254-25262. PMC: 7568239. DOI: 10.1073/pnas.2010722117. View

17.

Di Dalmazi G, Maltoni G, Bongiorno C, Tucci L, Di Natale V, Moscatiello S . Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study. BMJ Open Diabetes Res Care. 2020; 8(2). PMC: 7594202. DOI: 10.1136/bmjdrc-2020-001664. View

18.

Dobson C . Cardiac Sequelae of COVID-19 in Children and Young Adults. Pediatr Ann. 2021; 50(3):e128-e135. DOI: 10.3928/19382359-20210224-01. View

19.

Pitocco D, Viti L, Tartaglione L, Di Leo M, Rizzo G, Manto A . Diabetes and severity of COVID-19: What is the link?. Med Hypotheses. 2020; 143:109923. PMC: 7260494. DOI: 10.1016/j.mehy.2020.109923. View

20.

Ludvigsson J . Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020; 109(6):1088-1095. PMC: 7228328. DOI: 10.1111/apa.15270. View